A novel imidazo[1,2-a]pyridine derivative and its co-administration with curcumin exert anti-inflammatory effects by modulating the STAT3/NF-κB/iNOS/COX-2 signaling pathway in breast and ovarian cancer cell lines

Havva Afshari ¹ , Shokoofe Noori ¹ * , Mitra Nourbakhsh ^2,3, Azam Daraei ¹, Mahsa Azami Movahed ⁴, Afshin Zarghi ⁴

Cited by CrossRef: 0

1- Wahnou H, El Kebbaj R, Liagre B, Sol V, Limami Y, Duval R. Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy. Pharmaceutics. 2025;17(1):114 [Crossref]

2- Hasan T, Mohammadi M, Jabbari A, Flaifel H, Mirzaei H. Nutraceuticals Targeting Cannabinoid Receptor 1 and Transient Receptor Potential Vanilloid 1 for Pain Relief: A Computational Screening Approach. 2025; [Crossref]

3- Martinho L, de Lima D, Praciano V, Oliveira S, Kleber Z Andrade C. Phytotoxicity Study of (Amino)imidazo[1,2-a]pyridine Derivatives Toward the Control of Bidens pilosa, Urochloa decumbens, and Panicum maximum Weeds. J Agric Food Chem. 2025;73(1):298 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons